Showing results (231-240 of 465) with videos related to

Sort By:
Pageof 47
Emerging Microbes & Infections|June 22, 2017
HIV-1 gp41-targeting fusion inhibitory peptides enhance the gp120-targeting protein-mediated inactivation of HIV-1 virionsQianqian Qi, Qian Wang, Weizao Chen, et al.
Frontiers in Oncology|October 25, 2023
Human antibody VH domains targeting uPAR as candidate therapeutics for cancersXiaojie Chu, Wei Li, Margaret G Hines, et al.
The Journal of Biological Chemistry|January 18, 2003
Evidence for CD4-enchanced signaling through the chemokine receptor CCR5Robert Staudinger, Sanjay K Phogat, Xiaodong Xiao, et al.
SAR and QSAR in Environmental Research|April 29, 2004
Predicting the biodegradation products of perfluorinated chemicals using CATABOLS Dimitrov, V Kamenska, J D Walker, et al.
Current Drug Discovery Technologies|July 19, 2013
Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domainsWeizao Chen, Rui Gong, Tianlei Ying, et al.
Journal of Virology|July 1, 2011
Engineered single human CD4 domains as potent HIV-1 inhibitors and components of vaccine immunogensWeizao Chen, Yang Feng, Rui Gong, et al.
Science (New York, N.Y.)|October 25, 1996
Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell linesC K Lapham, J Ouyang, B Chandrasekhar, et al.
Frontiers in Microbiology|August 10, 2012
Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencingPonraj Prabakaran, Zhongyu Zhu, Weizao Chen, et al.
Pageof 47